• Теги
    • избранные теги
    • Компании1595
      • Показать ещё
      Разное433
      • Показать ещё
      Страны / Регионы346
      • Показать ещё
      Международные организации19
      • Показать ещё
      Люди101
      • Показать ещё
      Издания52
      • Показать ещё
      Формат40
      Показатели29
      • Показать ещё
Выбор редакции
18 сентября, 00:35

«Нацимбио» нашла индийского партнера

Индийская Mylan Laboratories будет поставлять «дочке» госкорпорации «Ростех» – Национальной иммунобиологической компании («Нацимбио») субстанции для производства препаратов против ВИЧ, сообщил «Интерфакс». Соответствующее рамочное соглашение стороны подписали в пятницу, подтвердил представитель «Ростеха». Подробности он комментировать отказался.

Выбор редакции
18 сентября, 00:35

«Нацимбио» нашла партнера для создания лекарства против ВИЧ в Индии

Индийская Mylan Laboratories будет поставлять «дочке» госкорпорации «Ростех» – Национальной иммунобиологической компании («Нацимбио») субстанции для производства препаратов против ВИЧ, сообщил «Интерфакс». Соответствующее рамочное соглашение стороны подписали в пятницу, подтвердил представитель «Ростеха». Подробности он комментировать отказался.

Выбор редакции
15 сентября, 14:04

"Нацимбио" начнет производить лекарства от ВИЧ совместно с Mylan laboratories

Как заявил генеральный директор госкорпорации Сергей Чемезов, сотрудничество с индийской компанией позволит снизить стоимость лекарств на российском рынке

15 сентября, 00:01

Biosimilar 2017 Progress Report: Stocks in Focus

The biosimilar space remains in the spotlight as a number of regulatory decisions are pending.

14 сентября, 08:09

The Ridiculously Overpriced Items You Keep Paying Way Too Much Money For

The math doesn’t lie. Americans continue to pay highly inflated prices for these common items -- some of which give them no choice.

Выбор редакции
12 сентября, 22:33

Teva's New CEO Brings No Relief: Generic Drugmakers to Dump

  • 0

The New CEO appointment at Teva (TEVA has once again shifted focus to the Generic Drug industry, which is presently facing several challenges.

11 сентября, 15:17

Teva Hires Kare Schultz as CEO: Is a Recovery in the Cards?

Teva Pharmaceutical (TEVA) announced the appointment of H. Lundbeck's Kare Schultz as President and Chief Executive Officer (CEO).

08 сентября, 15:16

Frontrunning: September 8

  • 0

Hurricane Irma threatens power losses for millions in Florida (Reuters) Back-to-Back Hurricanes to Test FEMA Reforms (WSJ) How Would the U.S. Defend Against a North Korean Nuclear Attack? (BBG) Russia says too early to decide on U.N. resolution on North Korea: Interfax (Reuters) Strongest Quake in a Century Hits Mexico, 15 Reported Dead (BBG) Ryan Bears Brunt of GOP Anger Over Trump’s Deal With Democrats (BBG) Trump’s Debt Deal Moves Forward, With Help From Democrats (WSJ) Houston CEOs Race to Mend a Storm-Battered Workforce (WSJ) Consumers Struggle to Get Answers From Equifax After Hack (BBG) Irma Batters Reinsurance Mutual Fund as Hurricane Nears Florida (BBG) Uber Faces FBI Probe Over?Program Targeting Rival Lyft (WSJ) Three Equifax Managers Sold Stock Before Cyber Hack Revealed (BBG) Trump anger at Cohn raises doubts about his White House tenure: sources (Reuters) U.S. Wants Shkreli Jailed After Offer of Clinton Hair Bounty (BBG) Erdogan urges U.S. to review 'political' charges against (Reuters) Israel Has a Playbook for Dealing With North Korea (BBG) Will Saudi Aramco deliver world record profit for next year's IPO? (Reuters) Monsanto fights to sell Arkansas farmers herbicide linked to crop damage (Reuters)   Overnight Media Digest WSJ - Amazon.com Inc on Thursday launched an plan to establish a second corporate headquarters in North America, creating up to 50,000 high-paying jobs, many in software development and most of them new. on.wsj.com/2wNapaV - President Donald Trump signaled he was open to making more deals with Democrats in Congress despite anger from fellow Republicans over a bipartisan agreement that passed the Senate Thursday. on.wsj.com/2wMN355 - Authorities on Thursday ordered more than 650,000 people to evacuate the Miami area as Hurricane Irma churned toward a possible collision with the mainland U.S. and after the Category 5 storm killed at least 11 people in the Caribbean. on.wsj.com/2wN0SAz - Guo Wengui, Chinese businessman who has alleged corruption among China's political and corporate elites, said he is seeking asylum in the U.S., Beijing tries to discredit him and try him on criminal charges. on.wsj.com/2wNhKaq - President Donald Trump refused to rule out military action against North Korea on Thursday, but he stopped short of answering a reporter's question as to whether he would tolerate a nuclearized North Korean state if the threat were contained. on.wsj.com/2wMKxf5 - Equifax Inc said Thursday that hackers gained access to some of its systems, potentially compromising the personal information of roughly 143 million U.S. consumers. on.wsj.com/2wMWJN9 - The Food and Drug Administration issued a scathing warning letter to a Pfizer Inc unit that manufactures the emergency auto-injector EpiPen, saying the company "failed to thoroughly investigate" product failures depsite patients' deaths. on.wsj.com/2wMWWQ8 - Eli Lilly Co announced plans on Thursday to cut roughly 8% of its global workforce, which includes 2,000 jobs in the U.S. on.wsj.com/2wMNIn5   FT * U.S. President Donald Trump said on Thursday he would prefer to avoid military action to deal with North Korea’s nuclear threat, but said previous diplomatic efforts have failed to pressure Pyongyang from developing its missiles. * British PR firm Bell Pottinger told its staff that it is likely to go under administration as early as next Monday after it failed to find a buyer, according to people familiar with the matter. * Saudi Arabia is revising parts of an economic development plan released a year ago but key policies, including fiscal reforms and a massive privatisation programme, according to an internal document seen by the Financial Times.   NYT - Equifax Inc, one of the three major consumer credit reporting agencies, said on Thursday hackers had gained access to company data that potentially compromised sensitive information for 143 million American consumers, including Social Security numbers and driver's license numbers. nyti.ms/2xTtBRI - Amazon.com Inc took the unusual step on Thursday of announcing it wants a second home outside Seattle, starting what is sure to be a fierce bidding war to lure Amazon — and the thousands of high-paying jobs it will bring to town — using a combination of tax breaks and other sweeteners. nyti.ms/2wMJ1sQ - Two planned streaming services of Walt Disney Co took clearer shape on Thursday, as the entertainment giant vowed to bring "Star Wars" and Marvel movies to one and proposed a novel approach to the other: sports á la carte. nyti.ms/2f7TyFJ - The Food and Drug Administration this week accused the drugmaker Pfizer Inc of failing to properly investigate reports of malfunctioning EpiPens, including incidents when patients died or became severely ill after the device failed to work. Pfizer manufactures the EpiPen, which treats allergic reactions, for the drugmaker Mylan NV. nyti.ms/2ePWWZ0   Canada THE GLOBE AND MAIL Veteran Canadian tech executive Les Rechan is joining Ottawa messaging and data-transfer technology firm Solace Corp as president and CEO, four months after the takeover of his previous company, Halogen Software Inc. (tgam.ca/2xQZud7) TransCanada Corp is seeking to halt a federal review of its C$15.7 billion ($12.97 billion) Energy East pipeline, raising the possibility the project could get scrapped in a move that would spare Prime Minister Justin Trudeau from having to make a politically charged decision on the project's fate. (tgam.ca/2xRwySm) The mayors of several Canadian cities are competing to become the home of Amazon.com Inc's second headquarters, a massive complex the company says comes with up to 50,000 jobs and more than $5-billion in investment over the next 15 years. (tgam.ca/2xRi0lk) NATIONAL POST Bell Media, the owner of TV networks CTV and TSN, on Thursday announced the promotion of three senior executives after its president of media sales, Steve Garvie, took a job as CEO of media investment firm GroupM's Canadian operations. (bit.ly/2xQZQAt)   Britain The Times - Eicher Motors Ltd, the Indian company that owns Royal Enfield, is set to make a binding bid to buy Volkswagen-owned Ducati of up to $2 billion by the deadline at the end of the month, according to a report in the Economic Times. bit.ly/2xaewxz - The votes of a single City investment house, Schroders Plc , saved Keith Hellawell, the Sports Direct International Plc chairman. Schroders confirmed that it had voted its 5.05 percent stake in support of Hellawell at the retail group's annual meeting on Wednesday. bit.ly/2xauKXg The Guardian - Jaguar Land Rover Automotive Plc has become the latest large carmaker to say it will stop launching new models solely powered by internal combustion engines, two months after Volvo AB pledged to do so. bit.ly/2xa18cE - Increases in payouts to victims of car crashes and botched operations are to be scaled back after a furious backlash by the insurance industry against Ministry of Justice plans. bit.ly/2xadNfv The Telegraph - Bovis Homes Group PLC's share price has soared more than 8 percent as its new Chief Executive Greg Fitzgerald updated investors on his strategic review. bit.ly/2xa38Sc - Charlotte Hogg, who resigned from the Bank of England earlier this year after failing to declare her brother's job at Barclays Plc, has been named the new head of Visa Inc's Europe business. bit.ly/2x9V1oy Sky News - Public relations firm Bell Pottinger Private Ltd is on the brink of collapsing into administration, just days after controversial work for a South African client led to its expulsion from its industry association. bit.ly/2xa9wZD - British Airways faces union opposition over its plans to address a "significant and growing" funding deficit by closing its main pension scheme. bit.ly/2xaachM The Independent - European Central Bank President Mario Draghi has sounded a warning about the rapid appreciation of the euro and said there were concerns expressed by "most members" of the ECB's governing council at its meeting this week over the euro exchange rate. ind.pn/2xabR75 - Consumer goods giant Unilever NV has snapped up tea group Pukka Herbs Ltd. ind.pn/2xasgbq  

15 августа, 00:12

What David Tepper Bought And Sold In Q2: The Full Breakdown

Remember when several months ago the news that David Tepper disclosed that his Appaloosa bought a (tiny 100,000 share) take in Snapchat in Q1, sending the stock briefly higher, especially after he said that he would add more if the price fell below its IPO price of $17? Well, according to his just released 13F, he didn't, and in fact has since dissolved his entire stake in the company that has since pivoted to dancing hotdogs. That triviality aside, what was most notable about Tapper's Q2 holdings is that in addition to boosting several key tech names, as well as opening a new $500+ million position in Alibaba, he took his total long equity holdings to just over $6.7 billion as of June 30, up from $6.1 billion at the end of March, the highest net long exposure since September 2014. Here is a breakdown of the key position changes for Tepper as of March 31: Top new positions: Alibaba, QQQ ETF, IBB ETF, Dollar General, Stryker, Energy Transfer Equity, L Brands, Wells Fargo, Cemex, Top exits: Regions Financial, Pfizer, Mylan, Teva, Symantec, Charter, ArcelorMittal, United Continental, TerraForm, US Steel Boosted stakes: Micron, Google, Western Digital, Facebook, Apple, United Rentals, Thermo Fisher, UnitedHealth Group, Delta Airlines Cut stakes: Southwest, General Motors, Allergan, Kinder Morgan, Williams Partners, HCA, Nucor Steel, Boston Scientific, Mohawk Industries, PNC Financial And the full visual summary: bold are additions; green are new positions; Red are exits.

28 июня, 16:26

Novartis' Erelzi, Biosimilar of Enbrel Approved In Europe

Novartis AG (NVS) announced that the European Commission (EC) has approved Erelzi ??? the biosimilar version of Enbrel.

24 июня, 14:37

California activist Tom Steyer adds health care to his brand

Joining the drug price battle could boost the political fortunes of the California billionaire.

Выбор редакции
24 июня, 00:37

The EpiPen maker's chairman earned more than $97 million last year - and investors aren't happy

Even among the tiny group of companies whose pay doesn't meet shareholders' muster, Mylan has a particularly poor track record.

Выбор редакции
24 июня, 00:30

The EpiPen maker's chairman earned more than $97 million last year - and investors aren't happy

Even among the tiny group of companies whose pay doesn't meet shareholders' muster, Mylan has a particularly poor track record.

Выбор редакции
22 июня, 22:09

EpiPen maker's $98 million payout is just way too much, shareholders say

Mylan just got a rare scolding from shareholders fuming over a $98 million pay package for its former CEO.

22 июня, 22:09

EpiPen maker's $98 million payout is just way too much, shareholders say

EpiPen maker Mylan got a rare scolding from shareholders who are fuming over a $98 million pay package for its former CEO.

Выбор редакции
22 июня, 19:14

Mylan investors reject bumper executive payouts

Shareholders vote against remuneration follows outcry over high EpiPen price

Выбор редакции
22 июня, 00:36

Drugmaker Mylan Gets Tax Boost From Refined Coal

function onPlayerReadyVidible(e){'undefined'!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if('object'==typeof commercial_video){var a='',o='m.fwsitesection='+commercial_video.site_and_category;if(a+=o,commercial_video['package']){var c='&m.fwkeyvalues=sponsorship%3D'+commercial_video['package'];a+=c}e.setAttribute('vdb_params',a)}i(e.vdb_Player)}else{var t=arguments.callee;setTimeout(function(){t(e,i)},0)}}(document.getElementById('vidible_1'),onPlayerReadyVidible); NEW YORK, June 21 (Reuters) - Mylan N.V. is best known for producing EpiPen emergency allergy treatments and generic drugs. But a non-pharmaceutical offering – refined coal – has quietly generated hundreds of millions of dollars of tax credits for the company over the last six years that have boosted its bottom line, according to a Reuters review of company filings. Since 2011, Mylan has bought 99 percent stakes in five companies across the U.S. that own plants which process coal to reduce smog-causing emissions. It then sells the coal at a loss to power plants to generate the real benefit for the drug company: credits that allow Mylan to lower its own tax bill. These refined coal credits were approved by Congress in 2004 in order to incentivize companies to fund production of cleaner coal. They are available to any company that is willing to invest the capital, and are set to expire after 2021. Mylan is one of only a few public companies, and the only publicly-traded pharmaceutical maker, that uses these tax credits, a Reuters review of a comprehensive database of filings with the U.S. Securities and Exchange Commission found. It is possible other companies receive an immaterial amount of the tax credits and decline to disclose them. Future tax credits could prove valuable to Mylan, which has seen sales of its flagship EpiPen allergy treatment sag after consumer outrage over the allergy treatment’s $600 list price. The pricing issue, which has drawn scrutiny from members of Congress and the U.S. Department of Justice, and Chairman Robert Coury’s nearly $100 million pay package last year have caused a group of investors to launch an effort to vote down the company’s board at its annual meeting on Thursday. Mylan already carries a low tax rate after moving its headquarters overseas in 2015. The coal credits helped the company lower its effective tax rate further, to just over four percent in 2014 and 7.4 percent in 2015. Last year, the company actually had a tax benefit of $358 million, giving it an effective tax rate of negative 294 percent. Mylan confirmed Reuters’ calculations based on figures in the tax footnotes in the company’s annual reports. According to these calculations, Mylan used more than $100 million of “clean energy and research” tax credits in both 2016 and 2015, and around $95 million in 2014. A person familiar with the matter told Reuters these coal operations have increased Mylan’s net earnings by around $40 million to $50 million in each of the past two years. That accounts for around 9 percent of the company’s earnings last year and more than 5 percent of its 2015 earnings. Mylan has disclosed very little about the tax credit strategy or its coal refining operations. It did not announce the coal deals when they occurred or disclose how much they cost. Mylan has not discussed them on its earnings conference calls and does not disclose exactly how much in tax credits they generate or what effect they are having on its bottom line. Wells Fargo analyst David Maris, who has a market perform rating on the company, said he believes that, from an investor standpoint, the coal transactions adds unnecessary complexity. “The average investor looking at their financial statements or their press releases, would have no idea what this is or how it flows through to their profit and loss statement,” he said.  “BEING MINDFUL OF TAX PLANNING” Mylan refers to losses and interest expense generated by its “clean energy investments,” as well as the fact that they qualify for tax credits, in tables and footnotes at the bottom of its earnings releases. In filings with regulators, it discloses some risks around the investments, their carrying value, and liabilities related to the investments. “It does sound like they are being mindful of tax planning,” said Lisa De Simone, professor of accounting at Stanford Graduate School of Business. “From the perspective of shareholder value, companies have all of the incentive in the world to try to reduce their tax payments, to increase net income and increase distributions to shareholders.” Mylan spokeswoman Nina Devlin said in an emailed statement that the tax credits are available to any interested company, and often “made outside of a company’s ordinary course of business, and companies involved in such projects range across a variety of non-energy related sectors.” Other companies Reuters found that take the credits include insurance brokerage and risk management services firm Arthur J Gallagher, Waste Management Inc and industrial supply company WW Grainger. The companies vary in their level of disclosure of the investments, but some disclose the number of tax credits they receive from the facilities. Devlin added that the health company recognizes that the production at the refined coal facilities will no longer be eligible for a tax credit beginning in 2022. “Nonetheless, on an ongoing basis, we consider appropriate opportunities for tax planning with respect to our global operations,” she added. New York City Comptroller Scott Stringer spoke out against the tax strategy when informed about it by Reuters. Stringer, who is leading the effort to vote down Mylan’s current board, oversees New York City pensions that together own more than 1.1 million shares of Mylan stock. “From the EpiPen pricing debacle to embracing complex tax avoidance strategies, Mylan’s board appears more focused on financial engineering than on the company’s core business,” he said.  COAL INTEREST DATES TO 2011 Mylan made the first investment in the coal producing plants in 2011, and expanded its total holdings to 5 plants by 2014. Mylan Chief Executive Heather Bresch, who has led the company since 2012, has coal country roots: she is the daughter of U.S. Senator Joe Manchin of West Virginia, the second largest coal-producing state in the country. The company declined to discuss the origin of why it adopted the tax strategy. Mylan says in its last two annual reports that its holdings are equity method investments in five limited liability corporations that own refined coal production plants, but does not name them. Reuters was able to identify these operations by reviewing lists of the company’s subsidiaries included with its annual reports. Mylan has 99 percent stakes in 5 LLCs that own refined coal plants: Canton Fuels Company in Illinois, Chouteau Fuels Company in Oklahoma, Deogun Manufacturing Company in Utah, Marquis Industrial Company in Indiana and Powder Street LLC in West Virginia. Mylan is booking losses from the plants, which is not unusual for these facilities. The companies often pay a middleman who manages the coal production facilities as well as other costs. Mylan recorded pre-tax losses of $92.3 million in 2016, $93.2 million in 2015 and $78.9 million in 2014 from the operations. The loss generated by the coal plants, as well as depreciation, is tax deductible, according to tax experts. But the tax credits generated by the facilities are extremely valuable. Last year, companies received $6.81 in tax credits for every ton of refined coal produced. Mylan produced around 16 million tons of refined coal last year, according to a person familiar with the matter. According to the same person, expenses – including costs paid for the assets and adjusted for tax deductions – equate to around 60 percent of the gross credits earned. (Editing by Caroline Humer and Edward Tobin) -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

19 июня, 23:56

Novartis (NVS) Biosimilar of MabThera Approved in the EU

Novartis AG (NVS) announced that its generic arm, Sandoz, has received European Commission (EC) approval for Rixathon.

16 июня, 18:28

Adamis Gets FDA Nod for Generic Version of Mylan's EpiPen

Shares of Adamis Pharmaceuticals Corporation (ADMP) soared more than 50% after the FDA approved the company's Epinephrine injection, USP, (0.3 mg Pre-filled single dose syringe) which is the generic version of Mylan N.V.'s (MYL) EpiPen.